Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

BIT:ERFO Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	7.68	5.83	5.74	4.62	4.84	3.9
Other Revenue	0.22	0.2	0.19	0.1	0.17	0.13
Revenue	7.9	6.03	5.93	4.72	5.01	4.03
Revenue Growth (YoY)	35.66%	1.69%	25.70%	-5.74%	24.09%	-11.71%
Cost of Revenue	4.74	3.49	3.33	2.27	2.24	1.69
Gross Profit	3.16	2.54	2.6	2.45	2.77	2.35
Selling, General & Admin	1.61	1.49	1.24	1.04	0.81	0.69
Amortization of Goodwill & Intangibles	0.53	0.38	0.37	0.3	0.16	0.01
Other Operating Expenses	-0.15	-0.17	-0.22	-0.21	-0.08	-0.13
Operating Expenses	2.3	2.01	1.76	1.46	1.19	0.86
Operating Income	0.85	0.52	0.84	0.99	1.58	1.49
Interest Expense	-0.05	-0.03	-0.03	-0.04	-0.02	-0.01
Currency Exchange Gain (Loss)	-0	-0	0	-	-	-
Other Non Operating Income (Expenses)	0.06	0.03	0.01	0	0	0.01
EBT Excluding Unusual Items	0.86	0.53	0.82	0.95	1.57	1.49
Gain (Loss) on Sale of Investments	-	-	-	-	-0.01	-
Pretax Income	0.86	0.53	0.82	0.95	1.56	1.49
Income Tax Expense	0.33	0.17	0.22	0.23	0.39	0.35
Net Income	0.37	0.35	0.59	0.72	1.17	1.14
Net Income to Common	0.37	0.35	0.59	0.72	1.17	1.14
Net Income Growth	-15.31%	-40.23%	-17.56%	-38.59%	2.28%	-12.99%
Shares Outstanding (Basic)	9	9	9	9	2	-
Shares Outstanding (Diluted)	9	9	9	9	2	-
Shares Change (YoY)	-0.15%	-0.26%	-4.44%	500.00%	-	-
EPS (Basic)	0.04	0.04	0.07	0.08	0.78	-
EPS (Diluted)	0.04	0.04	0.07	0.08	0.78	-
EPS Growth	-15.18%	-40.08%	-13.73%	-89.76%	-	-
Free Cash Flow	1.04	1.17	0.98	0.3	2.1	1.31
Free Cash Flow Per Share	0.12	0.14	0.11	0.03	1.40	-
Dividend Per Share	-	-	0.060	-	-	-
Gross Margin	39.95%	42.07%	43.84%	51.91%	55.26%	58.16%
Operating Margin	10.79%	8.68%	14.11%	20.91%	31.56%	36.87%
Profit Margin	4.73%	5.85%	9.95%	15.17%	23.29%	28.25%
Free Cash Flow Margin	13.16%	19.46%	16.58%	6.39%	41.87%	32.56%
EBITDA	1.44	1.07	1.56	1.61	2.02	1.78
EBITDA Margin	18.22%	17.66%	26.23%	34.07%	40.40%	44.09%
D&A For EBITDA	0.59	0.54	0.72	0.62	0.44	0.29
EBIT	0.85	0.52	0.84	0.99	1.58	1.49
EBIT Margin	10.79%	8.68%	14.11%	20.91%	31.56%	36.87%
Effective Tax Rate	37.96%	32.96%	27.58%	24.50%	25.06%	23.54%
Revenue as Reported	8.22	6.34	6.26	5.03	5.13	4.2

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.